After Pfizer’s News Of Promising Vaccine Results, Concerns Linger About Vaccine Equity for Under 12 Year Olds
Source: PeopleImages / Getty Pfizer announced a significant breakthrough on Monday regarding vaccinating elementary school-age children. New data from the vaccine trial for children under 12 showed the vaccine was safe for children 5-11 and had a similar immune system response as adults. As a part of the trial, children under 12 were given a modified…
